News
07-03-2026, 09:00 AM
The advent of immune checkpoint inhibitors (ICIs) has marked a paradigm shift in cancer treatment, yet a significant portion of breast cancer patients fail to respond to these therapies.
More... (https://www.news-medical.net/news/20260703/New-breast-cancer-classification-system-predicts-immunotherapy-response-success.aspx)
More... (https://www.news-medical.net/news/20260703/New-breast-cancer-classification-system-predicts-immunotherapy-response-success.aspx)